In recent years, our focus has centered around synthesizing and characterizing a series of glucoconjugates bearing boron clusters and investigating their biochemical foundations of GLUT1 targeted approach to BNCT in HNSCC cell models (Figure 1). This evidence concerns the gene SLC2A1 and head and neck squamous cell carcinoma.